Dr Akhil Santhosh
@tuttsakhil
Followers
562
Following
947
Statuses
1K
Specialist Med Onc (MVRCCRI) DM Med onc, AIIMS New Delhi(Gold Medallist) MD Medicine PGIMER MBBS JIPMER MRCP UK SCE(oncology) ECMO Married to Gopika sali
Calicut, Kerala.
Joined December 2023
Happy to share that I am among the recipients of the ASCO IDEA award 2025. Thanks to all my teachers and mentors in @aiims_newdelhi @OfficialJipmer and PGIMER @batraatulmd @DrGPrakash @oncologistindia @MVRCancerCentre @DrJasminPorwall @aparna96 @Amolpatel_dr @samdoc_mamc @ASCO
17
5
90
Lurbinectedin plus pembrolizumab in relapsed small cell lung cancer (SCLC): the phase I/II LUPER study - Journal of Thoracic Oncology @JTOonline
0
2
7
Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial - The Lancet Haematology
0
0
0
Isatuximab, bortezomib, lenalidomide, and limited dexa in patients with transplant-ineligible multiple myeloma (REST): ph2 single arm 👉Interesting data for omission of dexa after 2 cycles..helpful for elderly pts to avoid toxicities with long term dexa
0
0
0
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physicians - Cancer Treatment Reviews @myESMO
0
0
0
RT @Annals_Oncology: 🆕article in press from @EMN_EuMMnet: European Myeloma Network Group Review and Consensus Statement on Primary Plasma C…
0
1
0
Precision-Guided Durable Response From Venetoclax With Decitabine in a Patient With a Metastatic Refractory IDH2-Mutant Cholangiocarcinoma | JCO Precision Oncology @JCOPO_ASCO
0
2
3
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial - ESMO Open @myESMO
0
1
6
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study @TheLancet
0
0
2
European Myeloma Network Group Review and Consensus Statement on Primary Plasma Cell Leukemia - @Annals_Oncology
0
0
2
Tumour spread through air spaces is a determiner for treatment of clinical stage I non-small cell lung Cancer: Thoracoscopic segmentectomy vs lobectomy - Lung Cancer @LungCaJournal
0
2
13
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer - Lung Cancer @LungCaJournal
0
1
3
European Myeloma Network Group Review and Consensus Statement on Primary Plasma Cell Leukemia - Annals of Oncology @myESMO
0
0
1
Primary mediastinal large B-cell Lymphoma: Biological features, clinical characteristics and current treatment strategies - Cancer Treatment Reviews @myESMO
0
0
3
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial - European Journal of Cancer
0
1
2
Disease-free survival as surrogate for overall survival in esophageal cancer: an individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy - European Journal of Cancer
0
2
4
319O ALTA-3: A randomized trial of brigatinib (BRG) vs alectinib (ALC) in crizotinib (CRZ)-refractory advanced ALK+ NSCLC - Annals of Oncology 👉Similar outcomes for brigatinib and alectinib in 2nd line post crizotinib @Annals_Oncology
0
2
5